Disclosed herein, among other things, is a method for identifying a patient for anti-atherosclerotic therapy. According to an embodiment, at least one diagnostic test is performed to determine if a patient is indicated for anti-atherosclerotic therapy. At least one parameter indicative of circulatory health is sensed as part of the diagnostic test, in an embodiment. Anti-atherosclerotic therapy is provided to the patient if the patient is indicated for anti-atherosclerotic therapy. In various embodiments, a neural target is stimulated as part of the therapy, using a predetermined stimulation schedule to inhibit vascular inflammation.

 
Web www.patentalert.com

> Smooth Muscle Controller

~ 00369